Federal Circuit Affirms JMOL That Negated $107.5M Cancer Treatment Patent Verdict
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on July 9 saw no error in a Delaware federal judge’s decision to grant judgment as a matter of law...To view the full article, register now.
Already a subscriber? Click here to view full article